Adrian Woolfson
Director/Miembro de la Junta en ImmunoSCAPE Pte Ltd. .
Cargos activos de Adrian Woolfson
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
ImmunoSCAPE Pte Ltd.
 ImmunoSCAPE Pte Ltd. BiotechnologyHealth Technology ImmunoSCAPE Pte Ltd. develops immunotherapy and leveraging therapies. The firm focuses on immunotherapy and leveraging a unique high-dimensional immune profiling Platform. The company was founded by Choon-Peng Ng, Alessandra Nardin, Michael Fehlings and Evan Newell in 2016 and is headquartered in Singapore. | Director/Miembro de la Junta | 28/07/2021 | - |
Historial de carrera de Adrian Woolfson
Antiguos cargos conocidos de Adrian Woolfson.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 22/01/2019 | 24/06/2020 |
Nouscom AG
 Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | Director Técnico/Científico/I+D | 01/01/2018 | 01/11/2018 |
| PFIZER, INC. | Director Técnico/Científico/I+D | 01/01/2015 | 01/01/2018 |
Formación de Adrian Woolfson.
| University of Oxford | Undergraduate Degree |
| University of Cambridge | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 3 |
| Reino Unido | 3 |
| Suiza | 2 |
Operativa
| Chief Tech/Sci/R&D Officer | 3 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sectorial
| Health Technology | 5 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | Health Technology |
ImmunoSCAPE Pte Ltd.
ImmunoSCAPE Pte Ltd. BiotechnologyHealth Technology ImmunoSCAPE Pte Ltd. develops immunotherapy and leveraging therapies. The firm focuses on immunotherapy and leveraging a unique high-dimensional immune profiling Platform. The company was founded by Choon-Peng Ng, Alessandra Nardin, Michael Fehlings and Evan Newell in 2016 and is headquartered in Singapore. | Health Technology |
- Bolsa de valores
- Insiders
- Adrian Woolfson
- Experiencia
